20 February 2025 - Bayer is pleased to announce that Health Canada has granted marketing authorisation for Eylea HD (aflibercept injection 8 mg/0.07 mL), a new pre-filled syringe with integrated OcuClick dosing system. 

This new system will provide ophthalmologists with an efficient and simple way to deliver the 8 mg/0.07 mL of Eylea HD for the treatment of neovascular (wet) age-related macular degeneration and the treatment of diabetic macular oedema.

Read Bayer press release